clinical trial · NCT00861692
Clinical Management of Argatroban in Patients With Heparin Induced Thrombocytopenia Type II
Heparin-induced Thrombocytopenia Type IIargatroban
brief summary
The purpose of this study is to collect data on the clinical management of Argatroban in patients with suspected or confirmed heparin-induced thrombocytopenia Type II, with or without ongoing thrombosis who require parenteral antithrombotic therapy
started
Apr 1, 2009
primary completion
Feb 1, 2011
completion
Feb 1, 2011
last updated
Jan 6, 2026
official title
An Open-label, Multi-centre, Clinical Study to Collect Information on the Clinical Use of Argatroban in Patients With Heparin Induced Thrombocytopenia (HIT) Type II Who Require Parenteral Antithrombotic Therapy
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol